Okusaka T - Search Results

1

Multicenter cooperative case survey of hepatitis B virus reactivation by chemotherapeutic agents.

Takahashi H, Ikeda M, Kumada T, Osaki Y, Kondo S, Kusumoto S, Ohkawa K, Nadano S, Furuse J, Kudo M, Ito K, Yokoyama M, Okusaka T, Shimoyama M, Mizokami M. Takahashi H, et al. Among authors: okusaka t. Hepatol Res. 2015 Dec;45(12):1220-7. doi: 10.1111/hepr.12496. Epub 2015 Mar 2. Hepatol Res. 2015. PMID: 25627550

2

A phase II study of cisplatin in patients with biliary tract carcinoma.

Okada S, Ishii H, Nose H, Yoshimori M, Okusaka T, Aoki K, Iwasaki M, Furuse J, Yoshino M. Okada S, et al. Among authors: okusaka t. Oncology. 1994 Nov-Dec;51(6):515-7. doi: 10.1159/000227396. Oncology. 1994. PMID: 7970496 Clinical Trial.

3

Predictive factors for tumor response to systemic chemotherapy in patients with hepatocellular carcinoma.

Nagahama H, Okada S, Okusaka T, Ishii H, Ikeda M, Nakasuka H, Yoshimori M. Nagahama H, et al. Among authors: okusaka t. Jpn J Clin Oncol. 1997 Oct;27(5):321-4. doi: 10.1093/jjco/27.5.321. Jpn J Clin Oncol. 1997. PMID: 9390209

4

Past exposure to hepatitis B virus as a risk factor for hepatocellular carcinoma in patients with chronic liver disease.

Okada S, Sato T, Okusaka T, Ishii H, Ikeda M, Nakasuka H, Kosakamoto H, Yoshimori M, Wakabayashi K. Okada S, et al. Among authors: okusaka t. Br J Cancer. 1998 Jun;77(11):2028-31. doi: 10.1038/bjc.1998.337. Br J Cancer. 1998. PMID: 9667687 Free PMC article.

5

Undifferentiated carcinoma of the liver with neuroendocrine features: a case report.

Nakasuka H, Okada S, Okusaka T, Ishii H, Ikeda M, Ito R, Kosakamoto H, Yoshimori M, Nakanishi Y, Sakamoto M. Nakasuka H, et al. Among authors: okusaka t. Jpn J Clin Oncol. 1998 Jun;28(6):401-4. doi: 10.1093/jjco/28.6.401. Jpn J Clin Oncol. 1998. PMID: 9730157

6

A case of pancreatic cancer achieving symptomatic improvement with systemic chemotherapy.

Kosakamoto H, Okada S, Ueno H, Okusaka T, Ikeda M, Tanaka N, Yoshimori M, Matsuno Y. Kosakamoto H, et al. Among authors: okusaka t. Hepatogastroenterology. 1999 Jul-Aug;46(28):2621-4. Hepatogastroenterology. 1999. PMID: 10522052

7

Clinicopathological features in misdiagnosed pancreatic carcinoma.

Nagahama H, Okada S, Okusaka T, Ishii H, Ikeda M, Nakasuka H, Yoshimori M. Nagahama H, et al. Among authors: okusaka t. Hepatogastroenterology. 1999 Sep-Oct;46(29):2983-5. Hepatogastroenterology. 1999. PMID: 10576387

8

5-fluorouracil continuous infusion combined with cisplatin for advanced pancreatic cancer: a Japanese Cooperative Study.

Nose H, Okada S, Okusaka T, Furuse J, Yoshino M, Ogoshi K, Kato T, Miyaji M, Hoshino M, Ariyama J, Suyama M, Karasawa E, Yoshimori M. Nose H, et al. Among authors: okusaka t. Hepatogastroenterology. 1999 Nov-Dec;46(30):3244-8. Hepatogastroenterology. 1999. PMID: 10626195 Clinical Trial.

9

The usefulness of serial changes in serum CA19-9 levels in the diagnosis of pancreatic cancer.

Tanaka N, Okada S, Ueno H, Okusaka T, Ikeda M. Tanaka N, et al. Among authors: okusaka t. Pancreas. 2000 May;20(4):378-81. doi: 10.1097/00006676-200005000-00007. Pancreas. 2000. PMID: 10824692

10

A phase II study of sequential methotrexate and 5-fluorouracil in metastatic pancreatic cancer.

Ikeda M, Okada S, Ueno H, Okusaka T, Tanaka N, Kuriyama H, Yoshimori M. Ikeda M, et al. Among authors: okusaka t. Hepatogastroenterology. 2000 May-Jun;47(33):862-5. Hepatogastroenterology. 2000. PMID: 10919048 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

547 results

Search Page

Filters